ClearPoint Neuro Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de ClearPoint Neuro de 11.5% y 27.8% respectivamente, mientras que el BPA crecerá en un 15.2% al año.
Información clave
7.4%
Tasa de crecimiento de los beneficios
10.7%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 17.6% |
| Tasa de crecimiento de los ingresos | 26.5% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 08 Aug 2024 |
Actualizaciones recientes sobre el crecimiento futuro
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Recent updates
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 26%
Jul 11ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 09ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 58 | -14 | N/A | N/A | 1 |
| 12/31/2025 | 39 | -17 | -3 | -3 | 3 |
| 12/31/2024 | 31 | -18 | -10 | -10 | 3 |
| 6/30/2024 | 28 | -18 | -10 | -9 | N/A |
| 3/31/2024 | 26 | -21 | -13 | -12 | N/A |
| 12/31/2023 | 24 | -22 | -15 | -14 | N/A |
| 9/30/2023 | 22 | -22 | -17 | -16 | N/A |
| 6/30/2023 | 22 | -21 | -19 | -18 | N/A |
| 3/31/2023 | 21 | -18 | -19 | -18 | N/A |
| 12/31/2022 | 21 | -16 | -17 | -16 | N/A |
| 9/30/2022 | 20 | -16 | -18 | -17 | N/A |
| 6/30/2022 | 19 | -16 | -17 | -16 | N/A |
| 3/31/2022 | 17 | -16 | -15 | -15 | N/A |
| 12/31/2021 | 16 | -14 | -13 | -13 | N/A |
| 9/30/2021 | 16 | -12 | -12 | -12 | N/A |
| 6/30/2021 | 15 | -9 | -10 | -10 | N/A |
| 3/31/2021 | 14 | -7 | -8 | -8 | N/A |
| 12/31/2020 | 13 | -7 | -8 | -8 | N/A |
| 9/30/2020 | 12 | -7 | -6 | -6 | N/A |
| 6/30/2020 | 12 | -6 | -6 | -5 | N/A |
| 3/31/2020 | 12 | -6 | -5 | -5 | N/A |
| 12/31/2019 | 11 | -6 | -3 | -3 | N/A |
| 9/30/2019 | 10 | -5 | -3 | -3 | N/A |
| 6/30/2019 | 9 | -5 | -3 | -3 | N/A |
| 3/31/2019 | 8 | -6 | -3 | -3 | N/A |
| 12/31/2018 | 7 | -6 | -5 | -5 | N/A |
| 9/30/2018 | 7 | -7 | -6 | -6 | N/A |
| 6/30/2018 | 7 | -7 | -7 | -6 | N/A |
| 3/31/2018 | 7 | -7 | N/A | -7 | N/A |
| 12/31/2017 | 7 | -7 | N/A | -6 | N/A |
| 9/30/2017 | 7 | -7 | N/A | -5 | N/A |
| 6/30/2017 | 7 | -8 | N/A | -5 | N/A |
| 3/31/2017 | 6 | -8 | N/A | -6 | N/A |
| 12/31/2016 | 6 | -8 | N/A | -6 | N/A |
| 9/30/2016 | 6 | -8 | N/A | -6 | N/A |
| 6/30/2016 | 5 | -5 | N/A | -6 | N/A |
| 3/31/2016 | 5 | -7 | N/A | -7 | N/A |
| 12/31/2015 | 5 | -8 | N/A | -9 | N/A |
| 9/30/2015 | 4 | -9 | N/A | -9 | N/A |
| 6/30/2015 | 3 | -13 | N/A | -10 | N/A |
| 3/31/2015 | 4 | -11 | N/A | -9 | N/A |
| 12/31/2014 | 4 | -5 | N/A | -7 | N/A |
| 9/30/2014 | 4 | -4 | N/A | -7 | N/A |
| 6/30/2014 | 4 | -4 | N/A | -6 | N/A |
| 3/31/2014 | 3 | -4 | N/A | -7 | N/A |
| 12/31/2013 | 4 | -7 | N/A | -8 | N/A |
| 9/30/2013 | 5 | -4 | N/A | -8 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que CLPT siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que CLPT siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que CLPT siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (27.8% al año) de CLPT crezcan más rápidamente que los del mercado US (8.7% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (27.8% al año) de CLPT crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CLPT se prevé que sea elevada dentro de 3 años.